{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:30:22Z","timestamp":1791293422462,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.sapharm.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:29:20Z","timestamp":1752766160000},"page":"1013-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adherence and persistence to heart failure guideline-directed medical therapy: A systematic review of studies based on electronic healthcare data"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9419-7742","authenticated-orcid":false,"given":"Nerea","family":"B\u00e1ez-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Galindo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1742-251X","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Rodr\u00edguez-Ramallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"S\u00e1nchez-Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.sapharm.2025.07.005_bib1","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"10159","key":"10.1016\/j.sapharm.2025.07.005_bib2","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(18)31891-9","article-title":"Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"issue":"37","key":"10.1016\/j.sapharm.2025.07.005_bib4","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"8 Suppl 3","key":"10.1016\/j.sapharm.2025.07.005_bib5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.sapharm.2025.07.005_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"issue":"29","key":"10.1016\/j.sapharm.2025.07.005_bib7","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sapharm.2025.07.005_bib8","series-title":"Adherence to Long-Term Therapies : Evidence for Action","author":"Organization","year":"2003"},{"issue":"1","key":"10.1016\/j.sapharm.2025.07.005_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ehf2.14206","article-title":"Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014\u20132020","volume":"10","author":"\u00d8degaard","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.sapharm.2025.07.005_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1472-6963-12-270","article-title":"Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss","volume":"12","author":"Meddings","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/STROKEAHA.118.020372","article-title":"Promising use of big data to increase the efficiency and comprehensiveness of stroke outcomes research","volume":"50","author":"Ung","year":"2019","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.sapharm.2025.07.005_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15386\/mpr-1201","article-title":"An overview of the common methods used to measure treatment adherence","volume":"92","author":"Anghel","year":"2019","journal-title":"Med Pharm Rep"},{"issue":"1","key":"10.1016\/j.sapharm.2025.07.005_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10741-017-9656-x","article-title":"In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review","volume":"23","author":"Krueger","year":"2018","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.sapharm.2025.07.005_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cpt.1378","article-title":"Comparison of different strategies to measure medication adherence via claims data in patients with chronic heart failure","volume":"106","author":"Ihle","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/03007995.2017.1321534","article-title":"Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications","volume":"33","author":"Malo","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.sapharm.2025.07.005_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2025.07.005_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"BioMed Res Int"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.sapharm.2025.07.005_bib19","article-title":"Medication adherence and persistence in heart failure: a protocol for a systematic review and meta-analysis","author":"Ba\u00e9z-Guti\u00e9rrez","year":"2024","journal-title":"Farm Hosp"},{"issue":"10","key":"10.1016\/j.sapharm.2025.07.005_bib21","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1111\/bcp.15391","article-title":"Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: a scoping review and new tool TEN\u2010SPIDERS","volume":"88","author":"Dalli","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.sapharm.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/ejhf.2572","article-title":"Sacubitril\/Valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25 000 medicare beneficiaries","volume":"24","author":"Bhatt","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.sapharm.2025.07.005_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.cardfail.2021.03.012","article-title":"Sacubitril\/valsartan initiation and postdischarge adherence among patients hospitalized for heart failure","volume":"27","author":"Carnicelli","year":"2021","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009179","article-title":"Relation of household income to access and adherence to combination sacubitril\/valsartan in heart failure: a retrospective analysis of commercially insured patients","volume":"15","author":"Johnson","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"10.1016\/j.sapharm.2025.07.005_bib25","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3390\/pharmaceutics15112568","article-title":"Longitudinal trajectory modeling to assess adherence to sacubitril\/valsartan among patients with heart failure","volume":"15","author":"Mucherino","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.1465","article-title":"Real-world treatment patterns of sacubitril\/valsartan: a longitudinal cohort study in Germany","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.sapharm.2025.07.005_bib27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ahj.2013.03.007","article-title":"Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure","volume":"165","author":"Curtis","year":"2013","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.sapharm.2025.07.005_bib28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.cardfail.2021.11.013","article-title":"Medication trajectory and treatment patterns in medicare patients with heart failure and reduced ejection fraction","volume":"28","author":"Mentz","year":"2022","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.sapharm.2025.07.005_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.47519","article-title":"Neighborhood-level socioeconomic status and prescription fill patterns among patients with heart failure","volume":"6","author":"Mukhopadhyay","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.sapharm.2025.07.005_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ehjcvp\/pvv016","article-title":"Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival","volume":"1","author":"Witt","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"19","key":"10.1016\/j.sapharm.2025.07.005_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026187","article-title":"Adherence and discontinuation of optimal heart failure therapies according to age: a Danish nationwide study","volume":"11","author":"Garred","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib32","article-title":"Trajectories of sacubitril\/valsartan adherence among medicare beneficiaries with heart failure","volume":"3","author":"Huang","year":"2024","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"issue":"6","key":"10.1016\/j.sapharm.2025.07.005_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ehjcvp\/pvad045","article-title":"Initiation of eplerenone or spironolactone, treatment adherence, and associated outcomes in patients with new-onset heart failure with reduced ejection fraction: a nationwide cohort study","volume":"9","author":"Larsson","year":"2023","journal-title":"European Heart Journal - Cardiovascular Pharmacotherapy"},{"key":"10.1016\/j.sapharm.2025.07.005_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s40256-024-00643-7","article-title":"Treatment patterns, outcomes, and persistence to newly started heart failure medications in patients with worsening heart failure: a cohort study from the United States and Germany","author":"Michel","year":"2024","journal-title":"Am J Cardiovasc Drugs"},{"issue":"9","key":"10.1016\/j.sapharm.2025.07.005_bib35","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.clinthera.2010.08.002","article-title":"A retrospective, observational cohort analysis of a nationwide database to compare heart failure prescriptions and related health care utilization before and after publication of updated treatment guidelines in the United States","volume":"32","author":"Shafazand","year":"2010","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ehjcvp\/pvaa097","article-title":"Patient-reported outcomes and medication adherence in patients with heart failure","volume":"7","author":"Rasmussen","year":"2021","journal-title":"European Heart Journal - Cardiovascular Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14737167.2020.1718494","article-title":"Heart failure in the Veneto region of Italy: analysis of therapeutic pathways and the utilization of healthcare resources","volume":"20","author":"Degli","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hrtlng.2016.05.006","article-title":"Adherence, hospitalizations and treatment modifications among heart failure patients: a retrospective US claims database analysis","volume":"45","author":"Deschaseaux","year":"2016","journal-title":"Heart Lung"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MJT.0b013e3181ea3213","article-title":"Adherence to aldosterone-blocking agents in patients with heart failure","volume":"17","author":"Margolis","year":"2010","journal-title":"Am J Therapeut"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib40","article-title":"Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs","volume":"15","author":"Esposito","year":"2009","journal-title":"Am J Manag Care"},{"issue":"8","key":"10.1016\/j.sapharm.2025.07.005_bib41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cardfail.2011.04.011","article-title":"Impact of medication nonadherence on hospitalizations and mortality in heart failure","volume":"17","author":"Fitzgerald","year":"2011","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCULATIONAHA.106.669101","article-title":"Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes","volume":"116","author":"Gislason","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/phar.2107","article-title":"Association between medication adherence and the outcomes of heart failure","volume":"38","author":"Hood","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/pds.3790","article-title":"Influence of drug adherence and medical care on heart failure outcome in the primary care setting in Austria: quality of primary care and heart failure outcome","volume":"24","author":"Marzluf","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.sapharm.2025.07.005_bib45","first-page":"341","article-title":"Cardiovascular medication utilization and adherence among heart failure patients in rural and urban areas: a retrospective cohort study","volume":"31","author":"Murphy","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.sapharm.2025.07.005_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2021.11.018","article-title":"Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure","volume":"349","author":"Rea","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.sapharm.2025.07.005_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2021.02.016","article-title":"Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: a population-based retrospective study on 100785 patients","volume":"330","author":"Scalvini","year":"2021","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.sapharm.2025.07.005_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s40256-019-00367-z","article-title":"Adherence to disease-modifying therapy in patients hospitalized for HF: findings from a community-based study","volume":"20","author":"Spreafico","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"issue":"11","key":"10.1016\/j.sapharm.2025.07.005_bib49","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/ejhf.2024","article-title":"Effects of hyperkalaemia and non-adherence to renin\u2013angiotensin\u2013aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study","volume":"22","author":"Volterrani","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.sapharm.2025.07.005_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222868","article-title":"Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.sapharm.2025.07.005_bib51","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1592\/phco.26.8.1157","article-title":"Drug copayment and adherence in chronic heart failure: effect on cost and outcomes","volume":"26","author":"Cole","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib52","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-023-03467-7","article-title":"Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships","volume":"79","author":"Qin","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.sapharm.2025.07.005_bib53","article-title":"Medication adherence and medicare expenditure among beneficiaries with heart failure","volume":"18","author":"Lopert","year":"2012","journal-title":"Am J Manag Care"},{"issue":"6","key":"10.1016\/j.sapharm.2025.07.005_bib54","article-title":"Prescription drug spending and medication adherence among medicare beneficiaries with heart failure","volume":"25","author":"McGee","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib55","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.clinthera.2011.04.022","article-title":"Associations between prescription copayment levels and \u03b2-Blocker medication adherence in commercially insured heart failure patients 50 years and older","volume":"33","author":"Patterson","year":"2011","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.sapharm.2025.07.005_bib56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurjhf\/hft011","article-title":"Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care","volume":"15","author":"Gjesing","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.sapharm.2025.07.005_bib57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.sapharm.2017.10.010","article-title":"Adherence to the evidence-based heart failure drug treatment: are there sex-specific differences among new users?","volume":"14","author":"Kayibanda","year":"2018","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib58","first-page":"561","article-title":"Treatment initiation patterns, modifications, and medication adherence among newly diagnosed heart failure patients: a retrospective claims database analysis","volume":"22","author":"Deschaseaux","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.07.005_bib59","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ehf2.14206","article-title":"Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014\u20132020","volume":"10","author":"\u00d8degaard","year":"2023","journal-title":"ESC Heart Failure"},{"issue":"8","key":"10.1016\/j.sapharm.2025.07.005_bib60","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.clinthera.2007.08.015","article-title":"Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure","volume":"29","author":"Bagchi","year":"2007","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.sapharm.2025.07.005_bib61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/ijerph13020238","article-title":"Prevalence of heart failure and adherence to process indicators: which socio-demographic determinants are involved?","volume":"13","author":"Buja","year":"2016","journal-title":"Int J Environ Res Publ Health"},{"issue":"3","key":"10.1016\/j.sapharm.2025.07.005_bib62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCOUTCOMES.108.813600","article-title":"Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003","volume":"2","author":"Lamb","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib63","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archinte.1994.00420040107014","article-title":"Noncompliance with congestive heart failure therapy in the elderly","volume":"154","author":"Monane","year":"1994","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib64","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-023-03467-7","article-title":"Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships","volume":"79","author":"Qin","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.sapharm.2025.07.005_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajhp\/57.2.139","article-title":"Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization","volume":"57","author":"Roe","year":"2000","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.07.005_bib66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.amjcard.2015.04.058","article-title":"Medication adherence based on part D claims for patients with heart failure after hospitalization (from the atherosclerosis risk in communities study)","volume":"116","author":"Sueta","year":"2015","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.sapharm.2025.07.005_bib67","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005776","article-title":"Longitudinal heart failure medication use and adherence following left ventricular assist device implantation in privately insured patients","volume":"6","author":"Tan","year":"2017","journal-title":"JAHA"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib68","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11606-013-2692-x","article-title":"Race\/ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure","volume":"29","author":"Zhang","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4065\/mcp.2010.0732","article-title":"Medication adherence among community-dwelling patients with heart failure","volume":"86","author":"Dunlay","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.sapharm.2025.07.005_bib70","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007998","article-title":"Timing of postdischarge follow\u2010up and medication adherence among patients with heart failure","volume":"7","author":"Chang","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.sapharm.2025.07.005_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/03007995.2019.1670474","article-title":"Adherence to heart failure management medications following cardiac resynchronization therapy","volume":"36","author":"Shah","year":"2020","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.sapharm.2025.07.005_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ahj.2010.04.023","article-title":"The medicare drug benefit (part D) and treatment of heart failure in older adults","volume":"160","author":"Donohue","year":"2010","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib73","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0002-8703(99)70005-0","article-title":"Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure","volume":"138","author":"Roe","year":"1999","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib74","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2010.139","article-title":"Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure","volume":"88","author":"Setoguchi","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.sapharm.2025.07.005_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002022","article-title":"Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population","volume":"9","author":"Jonsson Holmdahl","year":"2022","journal-title":"Open Heart"},{"issue":"3","key":"10.1016\/j.sapharm.2025.07.005_bib76","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ejhf.2418","article-title":"Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017","volume":"24","author":"Zahir","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.sapharm.2025.07.005_bib77","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.53976","article-title":"Pharmacist-Led management model and medication adherence among patients with chronic heart failure: a randomized clinical trial","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib78","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1002\/ehf2.13508","article-title":"The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta-analysis","volume":"8","author":"Schumacher","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.sapharm.2025.07.005_bib79","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s12265-022-10262-9","article-title":"Impact of pharmacist-led heart failure clinic on optimization of guideline-directed medical therapy (PHARM-HF)","volume":"15","author":"Patil","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"issue":"4","key":"10.1016\/j.sapharm.2025.07.005_bib80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamacardio.2023.5627","article-title":"Interventions for optimization of guideline-directed medical therapy: a systematic review","volume":"9","author":"Tang","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.sapharm.2025.07.005_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014397","article-title":"Long-term use of secondary prevention medications for heart failure in Western Australia: a protocol for a population-based cohort study","volume":"6","author":"Qin","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2025.07.005_bib82","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2018.01290","article-title":"A systematic review of medication adherence thresholds dependent of clinical outcomes","volume":"9","author":"Baumgartner","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.sapharm.2025.07.005_bib83","series-title":"Patient Preference Adherence","first-page":"1","article-title":"Electronically monitored medication adherence predicts hospitalization in heart failure patients","author":"Riegel","year":"2014"},{"issue":"8","key":"10.1016\/j.sapharm.2025.07.005_bib84","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/1474515119860321","article-title":"Discontinuation of angiotensin-converting enzyme inhibitors or beta-blockers and the impact on heart failure hospitalization rates","volume":"18","author":"Knafl","year":"2019","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"1","key":"10.1016\/j.sapharm.2025.07.005_bib86","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ejhf.2008","article-title":"Self\u2010care of heart failure patients: practical management recommendations from the heart failure association of the european society of cardiology","volume":"23","author":"Jaarsma","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.sapharm.2025.07.005_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.3642","article-title":"How to handle polypharmacy in heart failure. A clinical consensus statement of the heart failure association of the ESC","author":"Stolfo","year":"2025","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.sapharm.2025.07.005_bib88","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1080\/03007995.2019.1601944","article-title":"Improving the accuracy of medication adherence measures using linked prescription and dispensation data: findings from the ESOSVAL cohort of patients treated with osteoporosis drugs","volume":"35","author":"Garc\u00eda-Sempere","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.sapharm.2025.07.005_bib89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0018578720918550","article-title":"Accurate medication adherence measurement using administrative data for frequently hospitalized patients","volume":"56","author":"Rasu","year":"2021","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.sapharm.2025.07.005_bib90","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3389\/fphar.2018.01353","article-title":"Estimating adherence based on prescription or dispensation information: impact on thresholds and outcomes. A real-world study with atrial fibrillation patients treated with oral anticoagulants in Spain","volume":"9","author":"Hurtado-Navarro","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125003833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125003833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:07:06Z","timestamp":1764990426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125003833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1551741125003833"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.07.005","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence and persistence to heart failure guideline-directed medical therapy: A systematic review of studies based on electronic healthcare data","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}